Company Filing History:
1 out of 10 
1 out of 1 
1 out of 1 Years Active: 2016
Title: Javier Munoz Gall: Innovator in Stem Cell Therapy
Introduction
Javier Munoz Gall is a notable inventor based in Bunyola, Spain. He has made significant contributions to the field of biotechnology, particularly in the area of stem cell therapy. His innovative work focuses on the treatment of airway immune inflammatory and lung diseases.
Latest Patents
Javier holds a patent for "Genetically modified mesenchymal stem cells expressing sST2 for the treatment of airway immune inflammatory and lung disease." This invention relates to mesenchymal stem cells (MSC) that are genetically modified to express sST2 or parts thereof. These cells are intended for use in treating various airway immune inflammatory and lung diseases, and importantly, they are not derived from human embryonic stem cells. The patent also encompasses pharmaceutical compositions that include these modified mesenchymal stem cells.
Career Highlights
Throughout his career, Javier has worked with prominent organizations such as the Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) and CIBER Enfermedades Respiratorias. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Javier has collaborated with esteemed colleagues, including Josep Maria Aran Perramon and Maria Jesus Cruz Carmona. These partnerships have enriched his research and fostered innovation in the field of stem cell therapy.
Conclusion
Javier Munoz Gall is a pioneering inventor whose work in genetically modified mesenchymal stem cells holds promise for treating serious respiratory conditions. His contributions to biotechnology continue to impact the field positively.